Overview Fundamentals Financials Technicals Corporate Action Shareholding Pattern Peer Comparison News Stock Analysis About Company FAQs

Windlas Biotech Ltd Share Price

Pharmaceuticals - Indian - Formulations

NSE: WINDLAS Small Cap ISIN: INE0H5O01029
As on 22 January 2025 at 18:36 IST
As on 22 January 2025 at 18:36 IST
978.75
-20.70
(-2.07%)
Over 1 Month
-2.24%
Over 6 Months
45.72%
Over 1 Year
115.05%
Over 3 Years
268.39%

Windlas Biotech Ltd Summary

Close ₹ 978.75
Open ₹ 1,014.45
High ₹ 1,019
Low ₹ 961.30
Volume 39,709
Net Turnover (in ₹) ₹ 2,51,83,726.95
52Wk High ₹ 1,198.25
52Wk Low ₹ 452.55
52Wk High / Low
452.55
1,198.25

Windlas Biotech Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 2,088.88
EPS (TTM) 29.27
Book Value (BV) 225.63
Div. Yield 0.55 %
P/E (TTM) 34.19
Price/Book Value 4.43
Delivery % 54.04 %
Face Value 5

Key Ratios

PE Ratio 18.32
PB Ratio 2.37
EV to Sales 1.65
PEG Ratio 0.49
ROA 12.74
ROE 13.63
Debt-Equity 0.01
Net Profit Margin 9.21
Operating Profit Margin 14.51

Windlas Biotech Ltd Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue644.42523.05472.64430.69331.34
Total Expenses567.33466.01427.07387.17299.20
Profit Before Tax77.0957.0445.5621.7424.67
Profit After Tax58.1942.6338.0915.5716.21
Operating Profit after Depreciation78.2057.8346.9844.8234.66

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets179.05110.3891.6295.9470.26
Total Non Current Assets194.92175.44109.36101.81170.46
Total Current Assets431.29353.54381.65194.31168.03
TOTAL ASSETS626.21528.98491.01296.12338.49
Total Shareholder's Fund449.94402.27394.78199.12209.66

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities108.9660.979.1311.4625.01
Net Cash used in Investing Activities-92.07-14.11-154.58-20.20-14.34
Net Cash used in Financing Activities-15.29-43.74130.090.78-5.44

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue644.42523.05472.64430.70329.81
Total Expenses567.40465.99426.60387.17299.24
Profit Before Tax77.0257.0646.0411.1830.57
Profit After Tax58.1442.6438.565.0122.46
Operating Profit after Depreciation78.1357.8447.4544.8232.94

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets179.05110.3891.6295.9468.43
Total Non Current Assets194.92175.47109.39101.85181.14
Total Current Assets431.24353.54381.63194.15162.66
TOTAL ASSETS626.16529.01491.03295.99343.80
Total Shareholder's Fund450.29402.67395.13198.99216.48

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities108.9160.98911.4520.87
Net Cash used in Investing Activities-92.07-14.11-154.31-20.19-9.16
Net Cash used in Financing Activities-15.29-43.74130.090.78-6.48

Particulars (in ₹ Cr.) 2024-09 2024-06 2024-03 2023-12 2023-09
Total Revenue187175.15171.29162.21152.67
Total Expenses163.95154.27149.28141.88133.99
Profit Before Tax20.2918.3122.6319.7918.30
Profit After Tax15.6613.4816.9915.1014.03
Operating Profit after Depreciation27.8925.0126.4523.4921.92

Particulars (in ₹ Cr.) 2024-09 2024-06 2024-03 2023-12 2023-09
Total Revenue187175.15171.29162.21152.67
Total Expenses163.95154.27149.35141.88133.99
Profit Before Tax20.2918.3122.5619.7918.30
Profit After Tax15.6613.4816.9515.1014.03
Operating Profit after Depreciation27.8925.0126.3823.4921.92

Windlas Biotech Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3
S1 988.65
S2 977.85
S3 959.70
Pivot 1,006.80
R1 1,017.60
R2 1,035.75
R3 1,046.55

Moving Average

20 SMA 1,015.20
50 SMA 1,033.52
100 SMA 980.15
200 SMA 825.41

Windlas Biotech Ltd Corporate Actions

Windlas Biotech Ltd

₹5.5/Share

Announcement Date 17 Sep 2024
Record Date 17 Sep 2024
Div Yield 110%

Windlas Biotech Ltd Peer Comparison

Company Price Market Cap (in ₹ Cr)
Windlas Biotech Ltd ₹1,000.65 ₹2,091.39
Sun Pharmaceuticals Industries Ltd ₹1,761.80 ₹4,22,714.84
Divis Laboratories Ltd ₹5,818.40 ₹1,54,460.24
Cipla Ltd ₹1,427.30 ₹1,15,270.75
Dr Reddys Laboratories Ltd ₹1,288.45 ₹1,07,511.36
Torrent Pharmaceuticals Ltd ₹3,157.60 ₹1,06,862.73

Windlas Biotech Ltd News

Windlas Biotech receives GMP certification for its new state-of-the-art injectable facility

From Food Safety & Drugs Administration Authority of Uttarakhand

10 Jan 2025, 03:42 pm

Windlas Biotech gains after receiving GMP certification for new injectable facility

Windlas Biotech added 1.76% to Rs 1,033.15 after the company announced that its new state-of-the-art injectable facility has received Good Manufacturing Practices (GMP) certification.

10 Jan 2025, 01:05 pm

Windlas Biotech allots 59,000 equity shares under ESOS

03 Jan 2025, 08:23 pm

Windlas Biotech announces board meeting date

On 12 November 2024

06 Nov 2024, 01:51 pm

Windlas Biotech schedules AGM

On 24 September 2024

03 Sep 2024, 05:28 pm

Windlas Biotech Ltd Stock Analysis

  1. Annual revenue for Windlas Biotech Ltd increased by 23.21% to ₹644.42 crore in FY 2024 from ₹523.05 crore in FY 2023.
  2. Annual Net Profit for Windlas Biotech Ltd increased by 36.35% to ₹58.14 crore in FY 2024 from ₹42.64 crore in FY 2023.
  3. Promoter Shareholding in Windlas Biotech Ltd remains unchanged by 0.00% in the most recent quarter, from 62.51% in September 2024 to 62.51% in December 2024.
  4. Windlas Biotech Ltd delivered a 1-year return of 115.05% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
  5. Windlas Biotech Ltd share price moved down by 2.07% from its previous close of INR ₹999.45. The latest Windlas Biotech Ltd share price is INR ₹978.75.
  6. Windlas Biotech Ltd share price today has been at a low of 961.30 and a high of 1,019. Over the past 52 weeks, the Windlas Biotech Ltd share price has seen a low of 452.55 and a high of 1,198.25.

FAQ’s

What is the share price of Windlas Biotech Ltd today?

Windlas Biotech Ltd share price as on 22 Jan 2025 is ₹ 978.75

What is the Market Cap of Windlas Biotech Ltd?

The market cap of Windlas Biotech Ltd stock is ₹2,088.88 Cr.

What is the PE Ratio of Windlas Biotech Ltd?

The Price to Earnings (P/E) Ratio of Windlas Biotech Ltd is 18.32

What is the PB Ratio of Windlas Biotech Ltd?

The Price to Book (P/B) Ratio of Windlas Biotech Ltd is 2.37

What is the 52 week high of Windlas Biotech Ltd Share Price?

The 52 week high of Windlas Biotech Ltd share price stands at ₹1,198.25

What is the 52 week low of Windlas Biotech Ltd Share Price?

The 52 week low of Windlas Biotech Ltd share price stands at ₹452.55

Get started with us today and
start building your wealth journey